{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:50Z","timestamp":1787020190664,"version":"build-2736575974"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T00:00:00Z","timestamp":1445212800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1732-9","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T06:22:02Z","timestamp":1445235722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Expression of Oct3\/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I\/II oral tongue squamous cell carcinoma"],"prefix":"10.1186","volume":"15","author":[{"given":"Noboru","family":"Habu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yorihisa","family":"Imanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Kameyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Tokumaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Shigetomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuninori","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,19]]},"reference":[{"key":"1732_CR1","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730\u20137.","journal-title":"Nat Med"},{"key":"1732_CR2","doi-asserted-by":"publisher","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","volume":"66","author":"MF Clarke","year":"2006","unstructured":"Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, et al. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006;66:9339\u201344.","journal-title":"Cancer Res"},{"key":"1732_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.med.58.062105.204854","volume":"58","author":"P Dalerba","year":"2007","unstructured":"Dalerba P, Cho RW, Clarke MF. Cancer stem cells: models and concepts. Annu Rev Med. 2007;58:267\u201384.","journal-title":"Annu Rev Med"},{"key":"1732_CR4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nrc1096","volume":"3","author":"DM Owens","year":"2003","unstructured":"Owens DM, Watt FM. Contribution of stem cells and differentiated cells to epidermal tumours. Nat Rev Cancer. 2003;3:444\u201351.","journal-title":"Nat Rev Cancer"},{"key":"1732_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105\u201311.","journal-title":"Nature"},{"key":"1732_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002637","volume":"3","author":"YC Chen","year":"2008","unstructured":"Chen YC, Hsu HS, Chen YW, Tsai TH, How CK, Wang CY, et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PloS one. 2008;3, e2637.","journal-title":"PloS one"},{"key":"1732_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature05372","volume":"445","author":"CA O'Brien","year":"2007","unstructured":"O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445:106\u201310.","journal-title":"Nature"},{"key":"1732_CR8","first-page":"5821","volume":"63","author":"SK Singh","year":"2003","unstructured":"Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003;63:5821\u20138.","journal-title":"Cancer Res"},{"key":"1732_CR9","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/nrd2137","volume":"8","author":"BB Zhou","year":"2009","unstructured":"Zhou BB, Zhang H, Damelin M, Geles KG, Grindley JC, Dirks PB. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov. 2009;8:806\u201323.","journal-title":"Nat Rev Drug Discov"},{"key":"1732_CR10","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100:3983\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1732_CR11","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/sj.onc.1209327","volume":"25","author":"L Patrawala","year":"2006","unstructured":"Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene. 2006;25:1696\u2013708.","journal-title":"Oncogene"},{"key":"1732_CR12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","volume":"1","author":"C Ginestier","year":"2007","unstructured":"Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell stem cell. 2007;1:555\u201367.","journal-title":"Cell stem cell"},{"key":"1732_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-1-59745-280-9_10","volume":"568","author":"C Li","year":"2009","unstructured":"Li C, Lee CJ, Simeone DM. Identification of human pancreatic cancer stem cells. Methods Mol Biol. 2009;568:161\u201373.","journal-title":"Methods Mol Biol"},{"key":"1732_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2407-9-9","volume":"9","author":"SD Huang","year":"2009","unstructured":"Huang SD, Yuan Y, Liu XH, Gong DJ, Bai CG, Wang F, et al. Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas. BMC Cancer. 2009;9:9.","journal-title":"BMC Cancer"},{"key":"1732_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nature09161","volume":"466","author":"AD Boiko","year":"2010","unstructured":"Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, Ly DP, et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature. 2010;466:133\u20137.","journal-title":"Nature"},{"key":"1732_CR16","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrc2499","volume":"8","author":"JE Visvader","year":"2008","unstructured":"Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 2008;8:755\u201368.","journal-title":"Nat Rev Cancer"},{"key":"1732_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.bbrc.2009.05.048","volume":"385","author":"YC Chen","year":"2009","unstructured":"Chen YC, Chen YW, Hsu HS, Tseng LM, Huang PI, Lu KH, et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun. 2009;385:307\u201313.","journal-title":"Biochem Biophys Res Commun"},{"key":"1732_CR18","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/hed.21315","volume":"32","author":"MR Clay","year":"2010","unstructured":"Clay MR, Tabor M, Owen JH, Carey TE, Bradford CR, Wolf GT, et al. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck. 2010;32:1195\u2013201.","journal-title":"Head Neck"},{"key":"1732_CR19","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.oraloncology.2008.10.003","volume":"45","author":"A Okamoto","year":"2009","unstructured":"Okamoto A, Chikamatsu K, Sakakura K, Hatsushika K, Takahashi G, Masuyama K. Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Oral Oncol. 2009;45:633\u20139.","journal-title":"Oral Oncol"},{"key":"1732_CR20","first-page":"89","volume":"22","author":"R Pries","year":"2008","unstructured":"Pries R, Witrkopf N, Trenkle T, Nitsch SM, Wollenberg B. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer. In Vivo. 2008;22:89\u201392.","journal-title":"In Vivo"},{"key":"1732_CR21","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1073\/pnas.0610117104","volume":"104","author":"ME Prince","year":"2007","unstructured":"Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A. 2007;104:973\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1732_CR22","doi-asserted-by":"crossref","unstructured":"Wei XD, Zhou L, Cheng L, Tian J, Jiang JJ, Maccallum J. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line. Head Neck. 2009;31:94\u2013101.","DOI":"10.1002\/hed.20935"},{"key":"1732_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.canlet.2009.08.010","volume":"289","author":"Q Zhang","year":"2010","unstructured":"Zhang Q, Shi S, Yen Y, Brown J, Ta JQ, Le AD. A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett. 2010;289:151\u201360.","journal-title":"Cancer Lett"},{"key":"1732_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062002","volume":"8","author":"T Imai","year":"2013","unstructured":"Imai T, Tamai K, Oizumi S, Oyama K, Yamaguchi K, Sato I, et al. CD271 defines a stem cell-like population in hypopharyngeal cancer. PloS one. 2013;8, e62002.","journal-title":"PloS one"},{"key":"1732_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1471-2407-14-173","volume":"14","author":"J Han","year":"2014","unstructured":"Han J, Fujisawa T, Husain SR, Puri RK. Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma. BMC Cancer. 2014;14:173.","journal-title":"BMC Cancer"},{"key":"1732_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1634\/stemcells.2005-0116","volume":"24","author":"GA Challen","year":"2006","unstructured":"Challen GA, Little MH. A side order of stem cells: the SP phenotype. Stem Cells. 2006;24:3\u201312.","journal-title":"Stem Cells"},{"key":"1732_CR27","doi-asserted-by":"publisher","first-page":"7340","DOI":"10.1038\/sj.onc.1206938","volume":"22","author":"LA Doyle","year":"2003","unstructured":"Doyle LA, Ross DD. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene. 2003;22:7340\u201358.","journal-title":"Oncogene"},{"key":"1732_CR28","doi-asserted-by":"crossref","unstructured":"Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996;183:1797\u2013806.","DOI":"10.1084\/jem.183.4.1797"},{"key":"1732_CR29","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1634\/stemcells.2005-0150","volume":"23","author":"JW Jonker","year":"2005","unstructured":"Jonker JW, Freeman J, Bolscher E, Musters S, Alvi AJ, Titley I, et al. Contribution of the ABC transporters Bcrp1 and Mdr1a\/1b to the side population phenotype in mammary gland and bone marrow of mice. Stem Cells. 2005;23:1059\u201365.","journal-title":"Stem Cells"},{"key":"1732_CR30","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1182\/blood.V99.2.507","volume":"99","author":"CW Scharenberg","year":"2002","unstructured":"Scharenberg CW, Harkey MA, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood. 2002;99:507\u201312.","journal-title":"Blood"},{"key":"1732_CR31","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm0901-1028","volume":"7","author":"S Zhou","year":"2001","unstructured":"Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, et al. The ABC transporter Bcrp1\/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med. 2001;7:1028\u201334.","journal-title":"Nat Med"},{"key":"1732_CR32","doi-asserted-by":"publisher","first-page":"14228","DOI":"10.1073\/pnas.0400067101","volume":"101","author":"C Hirschmann-Jax","year":"2004","unstructured":"Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, et al. A distinct \"side population\" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A. 2004;101:14228\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1732_CR33","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1158\/0008-5472.CAN-05-0592","volume":"65","author":"L Patrawala","year":"2005","unstructured":"Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res. 2005;65:6207\u201319.","journal-title":"Cancer Res"},{"key":"1732_CR34","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1634\/stemcells.2005-0282","volume":"24","author":"N Haraguchi","year":"2006","unstructured":"Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K, Barnard GF, et al. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells. 2006;24:506\u201313.","journal-title":"Stem Cells"},{"key":"1732_CR35","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1210\/en.2006-1553","volume":"148","author":"N Mitsutake","year":"2007","unstructured":"Mitsutake N, Iwao A, Nagai K, Namba H, Ohtsuru A, Saenko V, et al. Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology. 2007;148:1797\u2013803.","journal-title":"Endocrinology"},{"key":"1732_CR36","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/sj.bjc.6604185","volume":"98","author":"MR Loebinger","year":"2008","unstructured":"Loebinger MR, Giangreco A, Groot KR, Prichard L, Allen K, Simpson C, et al. Squamous cell cancers contain a side population of stem-like cells that are made chemosensitive by ABC transporter blockade. Br J Cancer. 2008;98:380\u20137.","journal-title":"Br J Cancer"},{"key":"1732_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.canlet.2008.12.015","volume":"277","author":"P Zhang","year":"2009","unstructured":"Zhang P, Zhang Y, Mao L, Zhang Z, Chen W. Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes. Cancer Lett. 2009;277:227\u201334.","journal-title":"Cancer Lett"},{"key":"1732_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011456","volume":"5","author":"J Song","year":"2010","unstructured":"Song J, Chang I, Chen Z, Kang M, Wang CY. Characterization of side populations in HNSCC: highly invasive, chemoresistant and abnormal Wnt signaling. PloS one. 2010;5, e11456.","journal-title":"PloS one"},{"key":"1732_CR39","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/hed.21325","volume":"32","author":"G Wan","year":"2010","unstructured":"Wan G, Zhou L, Xie M, Chen H, Tian J. Characterization of side population cells from laryngeal cancer cell lines. Head Neck. 2010;32:1302\u20139.","journal-title":"Head Neck"},{"key":"1732_CR40","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/lary.21032","volume":"121","author":"MH Tabor","year":"2011","unstructured":"Tabor MH, Clay MR, Owen JH, Bradford CR, Carey TE, Wolf GT, et al. Head and neck cancer stem cells: the side population. The Laryngoscope. 2011;121:527\u201333.","journal-title":"The Laryngoscope"},{"key":"1732_CR41","first-page":"2005","volume":"30","author":"G Sun","year":"2010","unstructured":"Sun G, Fujii M, Sonoda A, Tokumaru Y, Matsunaga T, Habu N. Identification of stem-like cells in head and neck cancer cell lines. Anticancer Res. 2010;30:2005\u201310.","journal-title":"Anticancer Res"},{"key":"1732_CR42","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/cncr.2820690526","volume":"69","author":"L Cerezo","year":"1992","unstructured":">Cerezo L, Millan I, Torre A, Aragon G, Otero J. Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer. A multivariate study of 492 cases. Cancer. 1992;69:1224\u201334.","journal-title":"Cancer"},{"key":"1732_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/1097-0142(19940101)73:1<187::AID-CNCR2820730132>3.0.CO;2-J","volume":"73","author":"CR Leemans","year":"1994","unstructured":"Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer. 1994;73:187\u201390.","journal-title":"Cancer"},{"key":"1732_CR44","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/01.mlg.0000161338.54515.b1","volume":"115","author":"MK Layland","year":"2005","unstructured":"Layland MK, Sessions DG, Lenox J. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. The Laryngoscope. 2005;115:629\u201339.","journal-title":"The Laryngoscope"},{"key":"1732_CR45","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/(SICI)1097-0142(19980415)82:8<1443::AID-CNCR2>3.0.CO;2-A","volume":"82","author":"T Asakage","year":"1998","unstructured":"Asakage T, Yokose T, Mukai K, Tsugane S, Tsubono Y, Asai M, et al. Tumor thickness predicts cervical metastasis in patients with stage I\/II carcinoma of the tongue. Cancer. 1998;82:1443\u20138.","journal-title":"Cancer"},{"key":"1732_CR46","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0002-9610(86)90305-3","volume":"152","author":"MJ Cunningham","year":"1986","unstructured":"Cunningham MJ, Johnson JT, Myers EN, Schramm Jr VL, Thearle PB. Cervical lymph node metastasis after local excision of early squamous cell carcinoma of the oral cavity. Am J Surg. 1986;152:361\u20136.","journal-title":"Am J Surg"},{"key":"1732_CR47","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/hed.2880140504","volume":"14","author":"CM Ho","year":"1992","unstructured":"Ho CM, Lam KH, Wei WI, Lau SK, Lam LK. Occult lymph node metastasis in small oral tongue cancers. Head Neck. 1992;14:359\u201363.","journal-title":"Head Neck"},{"key":"1732_CR48","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/hed.10130","volume":"24","author":"H Kurokawa","year":"2002","unstructured":"Kurokawa H, Yamashita Y, Takeda S, Zhang M, Fukuyama H, Takahashi T. Risk factors for late cervical lymph node metastases in patients with stage I or II carcinoma of the tongue. Head Neck. 2002;24:731\u20136.","journal-title":"Head Neck"},{"key":"1732_CR49","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/hed.20275","volume":"27","author":"M Pentenero","year":"2005","unstructured":"Pentenero M, Gandolfo S, Carrozzo M. Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: a review of the literature. Head Neck. 2005;27:1080\u201391.","journal-title":"Head Neck"},{"key":"1732_CR50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.oraloncology.2004.06.007","volume":"41","author":"M Goto","year":"2005","unstructured":"Goto M, Hasegawa Y, Terada A, Hyodo I, Hanai N, Ijichi K, et al. Prognostic significance of late cervical metastasis and distant failure in patients with stage I and II oral tongue cancers. Oral Oncol. 2005;41:62\u20139.","journal-title":"Oral Oncol"},{"key":"1732_CR51","first-page":"1136","volume":"46","author":"SH Ng","year":"2005","unstructured":"Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, et al. 18\u00a0F-FDG PET and CT\/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med. 2005;46:1136\u201343.","journal-title":"J Nucl Med"},{"key":"1732_CR52","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1054\/bjom.1999.0035","volume":"37","author":"JA Woolgar","year":"1999","unstructured":"Woolgar JA. Pathology of the N0 neck. Br J Oral Maxillofac Surg. 1999;37:205\u20139.","journal-title":"Br J Oral Maxillofac Surg"},{"key":"1732_CR53","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1158\/1078-0432.CCR-0533-3","volume":"10","author":"SC Lim","year":"2004","unstructured":"Lim SC, Zhang S, Ishii G, Endoh Y, Kodama K, Miyamoto S, et al. Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Clin Cancer Res. 2004;10:166\u201372.","journal-title":"Clin Cancer Res"},{"key":"1732_CR54","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1002\/cncr.21491","volume":"104","author":"K Myo","year":"2005","unstructured":"Myo K, Uzawa N, Miyamoto R, Sonoda I, Yuki Y, Amagasa T. Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM Stage I and II squamous cell carcinoma of the oral cavity. Cancer. 2005;104:2709\u201316.","journal-title":"Cancer"},{"key":"1732_CR55","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1245\/s10434-011-2052-1","volume":"19","author":"K Sakamoto","year":"2012","unstructured":"Sakamoto K, Imanishi Y, Tomita T, Shimoda M, Kameyama K, Shibata K, et al. Overexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage I\/II oral tongue squamous cell carcinoma after partial glossectomy. Ann Surg Oncol. 2012;19:612\u20139.","journal-title":"Ann Surg Oncol"},{"key":"1732_CR56","first-page":"1493","volume":"14","author":"F Suzuki","year":"2005","unstructured":"Suzuki F, Oridate N, Homma A, Nakamaru Y, Nagahashi T, Yagi K, et al. S100A2 expression as a predictive marker for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral cavity. Oncol Rep. 2005;14:1493\u20138.","journal-title":"Oncol Rep"},{"issue":"217","key":"1732_CR57","first-page":"211","volume":"11","author":"GF Huber","year":"2011","unstructured":"Huber GF, Zullig L, Soltermann A, Roessle M, Graf N, Haerle SK, et al. Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx. BMC Cancer. 2011;11(217):211\u20138.","journal-title":"BMC Cancer"},{"key":"1732_CR58","first-page":"823","volume":"13","author":"GM Seigel","year":"2007","unstructured":"Seigel GM, Hackam AS, Ganguly A, Mandell LM, Gonzalez-Fernandez F. Human embryonic and neuronal stem cell markers in retinoblastoma. Mol Vis. 2007;13:823\u201332.","journal-title":"Mol Vis"},{"key":"1732_CR59","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00432-006-0165-x","volume":"133","author":"Y Tani","year":"2007","unstructured":"Tani Y, Akiyama Y, Fukamachi H, Yanagihara K, Yuasa Y. Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression. J Cancer Res Clin Oncol. 2007;133:263\u20139.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1732_CR60","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1471-2407-9-61","volume":"9","author":"ZK Qin","year":"2009","unstructured":"Qin ZK, Yang JA, Ye YL, Zhang X, Xu LH, Zhou FJ, et al. Expression of Bmi-1 is a prognostic marker in bladder cancer. BMC Cancer. 2009;9:61.","journal-title":"BMC Cancer"},{"key":"1732_CR61","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/1097-0142(20010315)91:6<1114::AID-CNCR1107>3.0.CO;2-Y","volume":"91","author":"Y Nakanishi","year":"2001","unstructured":"Nakanishi Y, Ochiai A, Kato H, Tachimori Y, Igaki H, Hirohashi S. Clinicopathological significance of tumor nest configuration in patients with esophageal squamous cell carcinoma. Cancer. 2001;91:1114\u201320.","journal-title":"Cancer"},{"key":"1732_CR62","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.yexcr.2004.04.010","volume":"298","author":"F Montanaro","year":"2004","unstructured":"Montanaro F, Liadaki K, Schienda J, Flint A, Gussoni E, Kunkel LM. Demystifying SP cell purification: viability, yield, and phenotype are defined by isolation parameters. Exp Cell Res. 2004;298:144\u201354.","journal-title":"Exp Cell Res"},{"key":"1732_CR63","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/nrm1744","volume":"6","author":"M Boiani","year":"2005","unstructured":"Boiani M, Scholer HR. Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol. 2005;6:872\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1732_CR64","doi-asserted-by":"publisher","first-page":"a008128","DOI":"10.1101\/cshperspect.a008128","volume":"4","author":"J Nichols","year":"2012","unstructured":"Nichols J, Smith A. Pluripotency in the embryo and in culture. Cold Spring Harbor perspectives in biology. 2012;4:a008128.","journal-title":"Cold Spring Harbor perspectives in biology"},{"key":"1732_CR65","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature05934","volume":"448","author":"K Okita","year":"2007","unstructured":"Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448:313\u20137.","journal-title":"Nature"},{"key":"1732_CR66","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917\u201320.","journal-title":"Science"},{"key":"1732_CR67","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1002\/stem.1612","volume":"32","author":"KG Dowell","year":"2014","unstructured":"Dowell KG, Simons AK, Bai H, Kell B, Wang ZZ, Yun K, et al. Novel Insights into Embryonic Stem Cell Self-Renewal Revealed Through Comparative Human and Mouse Systems Biology Networks. Stem Cells. 2014;32:1161\u201372.","journal-title":"Stem Cells"},{"key":"1732_CR68","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/74199","volume":"24","author":"H Niwa","year":"2000","unstructured":"Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3\/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 2000;24:372\u20136.","journal-title":"Nat Genet"},{"key":"1732_CR69","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/carcin\/bgh321","volume":"26","author":"MH Tai","year":"2005","unstructured":"Tai MH, Chang CC, Kiupel M, Webster JD, Olson LK, Trosko JE. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis. 2005;26:495\u2013502.","journal-title":"Carcinogenesis"},{"key":"1732_CR70","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1634\/stemcells.2006-0426","volume":"25","author":"Y Babaie","year":"2007","unstructured":"Babaie Y, Herwig R, Greber B, Brink TC, Wruck W, Groth D, et al. Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells. Stem Cells. 2007;25:500\u201310.","journal-title":"Stem Cells"},{"key":"1732_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000026","volume":"1","author":"R Matoba","year":"2006","unstructured":"Matoba R, Niwa H, Masui S, Ohtsuka S, Carter MG, Sharov AA, et al. Dissecting Oct3\/4-regulated gene networks in embryonic stem cells by expression profiling. PloS one. 2006;1, e26.","journal-title":"PloS one"},{"key":"1732_CR72","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1634\/stemcells.2007-0401","volume":"26","author":"Y Guo","year":"2008","unstructured":"Guo Y, Mantel C, Hromas RA, Broxmeyer HE. Oct-4 is critical for survival\/antiapoptosis of murine embryonic stem cells subjected to stress: effects associated with Stat3\/survivin. Stem Cells. 2008;26:30\u20134.","journal-title":"Stem Cells"},{"key":"1732_CR73","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1535-6108(03)00270-8","volume":"4","author":"S Gidekel","year":"2003","unstructured":"Gidekel S, Pizov G, Bergman Y, Pikarsky E. Oct-3\/4 is a dose-dependent oncogenic fate determinant. Cancer cell. 2003;4:361\u201370.","journal-title":"Cancer cell"},{"key":"1732_CR74","doi-asserted-by":"publisher","first-page":"6533","DOI":"10.1158\/0008-5472.CAN-07-6642","volume":"68","author":"T Hu","year":"2008","unstructured":"Hu T, Liu S, Breiter DR, Wang F, Tang Y, Sun S. Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res. 2008;68:6533\u201340.","journal-title":"Cancer Res"},{"key":"1732_CR75","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1471-2407-13-82","volume":"13","author":"L Cao","year":"2013","unstructured":"Cao L, Li C, Shen S, Yan Y, Ji W, Wang J, et al. OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma. BMC Cancer. 2013;13:82.","journal-title":"BMC Cancer"},{"key":"1732_CR76","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0092-8674(03)00392-1","volume":"113","author":"I Chambers","year":"2003","unstructured":"Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell. 2003;113:643\u201355.","journal-title":"Cell"},{"key":"1732_CR77","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0092-8674(03)00393-3","volume":"113","author":"K Mitsui","year":"2003","unstructured":"Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell. 2003;113:631\u201342.","journal-title":"Cell"},{"key":"1732_CR78","doi-asserted-by":"publisher","first-page":"7150","DOI":"10.1038\/sj.onc.1207930","volume":"23","author":"I Chambers","year":"2004","unstructured":"Chambers I, Smith A. Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene. 2004;23:7150\u201360.","journal-title":"Oncogene"},{"key":"1732_CR79","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1158\/1078-0432.CCR-07-4404","volume":"14","author":"SH Chiou","year":"2008","unstructured":"Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, Tsai TH, et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res. 2008;14:4085\u201395.","journal-title":"Clin Cancer Res"},{"key":"1732_CR80","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1535-6108(04)00112-6","volume":"5","author":"CH Chung","year":"2004","unstructured":"Chung CH, Parker JS, Karaca G, Wu J, Funkhouser WK, Moore D, et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell. 2004;5:489\u2013500.","journal-title":"Cancer Cell"},{"key":"1732_CR81","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/ng1502","volume":"37","author":"P Roepman","year":"2005","unstructured":"Roepman P, Wessels LF, Kettelarij N, Kemmeren P, Miles AJ, Lijnzaad P, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet. 2005;37:182\u20136.","journal-title":"Nat Genet"},{"key":"1732_CR82","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442\u201354.","journal-title":"Nat Rev Cancer"},{"key":"1732_CR83","doi-asserted-by":"publisher","first-page":"9574","DOI":"10.1158\/0008-5472.CAN-08-2316","volume":"68","author":"J Zavadil","year":"2008","unstructured":"Zavadil J, Haley J, Kalluri R, Muthuswamy SK, Thompson E. Epithelial-mesenchymal transition. Cancer Res. 2008;68:9574\u20137.","journal-title":"Cancer Res"},{"key":"1732_CR84","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119:1420\u20138.","journal-title":"J Clin Invest"},{"key":"1732_CR85","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704\u201315.","journal-title":"Cell"},{"key":"1732_CR86","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nrc1694","volume":"5","author":"T Brabletz","year":"2005","unstructured":"Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer. 2005;5:744\u20139.","journal-title":"Nat Rev Cancer"},{"key":"1732_CR87","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/onc.2010.215","volume":"29","author":"A Singh","year":"2010","unstructured":"Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010;29:4741\u201351.","journal-title":"Oncogene"},{"key":"1732_CR88","doi-asserted-by":"publisher","first-page":"10433","DOI":"10.1158\/0008-5472.CAN-10-2638","volume":"70","author":"SH Chiou","year":"2010","unstructured":"Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, Hsieh WJ, et al. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res. 2010;70:10433\u201344.","journal-title":"Cancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1732-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1732-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1732-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T17:34:20Z","timestamp":1498239260000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1732-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,19]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1732"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1732-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,19]]},"article-number":"730"}}